naadp has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djerada, Z; Dukic, S; Millart, H; Peyret, H | 1 |
| Davidson, SM; Duchen, MR; Foote, K; Ganesan, A; Gosain, R; Graeff, R; Kunuthur, S; Patel, S; Tan, N; Tyser, R; Yellon, DM; Zhao, YJ | 1 |
| Babiker, F; Khalaf, A | 1 |
3 other study(ies) available for naadp and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor.
Topics: Animals; Arrhythmias, Cardiac; Blotting, Western; Cardiotonic Agents; Cyclic AMP; Enzyme Activation; Inositol Phosphates; Myocardial Reperfusion Injury; NADP; Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2 | 2013 |
Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore.
Topics: Animals; Calcium Channels; Calcium Signaling; Carbolines; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NADP; Piperazines; Rats, Sprague-Dawley; Time Factors | 2015 |
Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury.
Topics: Animals; Biomarkers; Calcium Signaling; Carbolines; Cardiac Pacing, Artificial; Coronary Vessels; Cyclic ADP-Ribose; Dantrolene; Heart; In Vitro Techniques; Ischemic Postconditioning; Lysosomes; Male; Muscle Relaxants, Central; Myocardial Reperfusion Injury; Myocardium; NADP; Piperazines; Rats, Wistar; Sarcoplasmic Reticulum | 2016 |